TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.

Nicholas D James,Wenyu Liu,Sarah Pirrie,Baljit Kaur,Carey Hendron,Daniel Ford,Anjali Zarkar,Richard Viney,Elizabeth Southgate,Amisha Desai,Syed A Hussain

BJU international（2022）

引用 0|浏览13

暂无评分

摘要

Phase I data demonstrate it is feasible and safe to add cetuximab to chemoradiotherapy. Exploratory analysis of phase II data provides evidence to consider further clinical evaluation of cetuximab in this setting.

查看译文

关键词

Muscle-invasive bladder cancer,cetuximab,chemoradiotherapy,clinical trial,feasibility

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要